Design, Synthesis, and Evaluation of p53Y220C Acetylation Targeting Chimeras (AceTACs).

Abstract excerpt

The well-known tumor suppressor p53 is mutated in approximately half of all cancers. The Y220C mutation is one of the major p53 hotspot mutations. Several small-molecule stabilizers of p53Y220C have been developed. We recently developed a new technology for inducing targeted protein acetylation, termed acetylation targeting chimera (AceTAC), and the first p53Y220C AceTAC that effectively acetylated p53Y220C at...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acetylation
• Share to Antineoplastic Agents
• Share to Cell Line, Tumor